PhRMA Statement on the Inflation Reduction Act Becoming Law

WASHINGTON, D.C. (August 16, 2022) – The Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl released the following statement after the president signed into law the Inflation Reduction Act, which includes a proposal that would allow the government to set prices for prescription medicines:

Related Keywords

Washington ,United States ,America Ph , ,Pharmaceutical Research ,Inflation Reduction Act ,Life Sciences ,Pharmaceutical Industry ,Pharmaceuticals ,Dc ,Association For Accessible Medicines ,Medication ,Pharmaceutical Research And Manufacturers Of America ,